SRF Ltd Share Price Today

Actions	Ex-Date	Record-Date
DividendsInterim Dividend of 50% at ₹5/Share	28-Jul-2026	28-Jul-2026
DividendsInterim Dividend of 50% at ₹5/Share	27-Jan-2026	27-Jan-2026
DividendsInterim Dividend of 40% at ₹4/Share	29-Jul-2025	29-Jul-2025
DividendsInterim Dividend of 36% at ₹3.6/Share	04-Feb-2025	04-Feb-2025

Mutual Fund Holder	Jul 26 Shares held	Aug 26 Shares held
Kotak Flexi Cap Fund - Growth	-	62.00 Lac (100%)
Kotak Mid Cap Fund - Regular Plan - Growth	-	40.58 Lac (100%)
SBI Midcap Fund - Regular Plan - Growth	21.00 Lac	21.00 Lac no change
Kotak Large & Mid Cap Fund - Growth	-	17.50 Lac (100%)
Mirae Asset Large & Midcap Fund - Regular Plan - Growth	15.42 Lac	15.42 Lac no change

Vibhu Jain

24 Sep • 6:07 PM · SEBI-Registered Analyst

SRF Ltd. try to understand stock with different parameter

SRF

Quality Assessment :- SRF Ltd. continues to demonstrate a solid quality profile, supported by consistent operational metrics. The company’s operating profit has exhibited a compound annual growth rate of approximately 8.25% over the past five years, indicating steady, albeit modest, expansion in core profitability. This growth rate suggests a stable business model with a degree of resilience in its specialty chemicals segment. Valuation :- The valuation aspect of SRF Ltd. has drawn particular attention in the recent evaluation update. The company is characterised by a very expensive valuation metric, with an enterprise value to capital employed ratio of 4.4. This elevated valuation multiple suggests that the market is pricing in significant growth expectations or premium attributes relative to capital base. Financial Trend:- SRF Ltd. presents a mixed picture. The company’s profits have risen by 56.6% over the past year, a strong indicator of recent operational success and improved earnings capacity. This robust profit growth contrasts with the stock’s return of -12.35% over the same period, suggesting a disconnect between market performance and underlying financial results. Technical Outlook:- a technical perspective, the stock’s recent movement has been bearish. Short-term returns show modest gains, with a 0.17% increase on the latest trading day and a 0.33% rise over the past week. However, the one-month and three-month returns are negative at -1.42% and -7.97% respectively, signalling downward momentum in the near term.

Lovelesh Sharma

19 Sep • 2:03 PM · SEBI-Registered Analyst

SRF: Reclaiming the 50-Day Average Is the Key Test

SRF

closed at ₹2,512 on 18 September, down 0.7% for the day. The stock has been correcting from the July high near ₹2,950 and continues to form lower highs, so the larger short-term structure remains under pressure. The 20-day moving average is at ₹2,493, while the 50-day moving average is higher at ₹2,533. Price has reclaimed the faster average but remains below the slower one. That makes ₹2,533 the first important hurdle. A sustained close above it would suggest that the recent decline is losing momentum and could open the way towards ₹2,600–₹2,650. On the downside, ₹2,450 is the immediate support zone. A close below that level would weaken the recent rebound and bring the ₹2,400 area back into focus. For now, SRF is a recovery attempt inside a broader correction, not yet a confirmed trend reversal. SRF’s diversified chemicals, packaging films and technical textiles businesses give it multiple growth drivers, but the chart still needs confirmation. The clean signal would be price moving above the 50-day average with follow-through.

Priyam Mehta

14 Sep • 2:05 PM · SEBI-Registered Analyst

SRF Limited [SRF] – Positional Important Levels:

SRF

SRF Limited [SRF] – Positional Important Levels: Support: ₹2,650 – ₹2,700 Resistance: ₹2,800 – ₹2,900 Structure: Neutral to positive technical setup Business: Diversified chemical and materials company with businesses across speciality chemicals, fluorochemicals, packaging films and technical textiles Key driver: Recovery in speciality chemicals, fluorochemicals demand and improving utilisation across key businesses Growth visibility: Capacity expansion in speciality chemicals and fluorochemicals provides long-term growth potential Earnings profile: Margin recovery and improved product mix remain important catalysts, while chemical cycles and input costs can create volatility Speciality chemicals: Higher-value products and new capacity additions can support better margins over the medium term Financial profile: Strong operating capabilities and diversified business segments provide resilience across chemical cycles Watch out for: Chemical pricing, global demand, raw-material costs, fluorochemical regulations, capex execution and currency movements Verdict: Positive bias while above ₹2,650–₹2,700 support zone Fresh momentum can emerge on a sustained breakout above ₹2,800 A move above ₹2,900 can indicate stronger positional momentum A decisive break below ₹2,650 may weaken the overall structure #FundamentalViews #TechnicalViews #WatchOutFor #Today’sTradingSetup #StockNews

Vibhu Jain

2 Sep • 7:17 PM · SEBI-Registered Analyst

SRF Ltd shifted towards a bearish stance

SRF

The technical assessment of SRF Ltd. has shifted towards a bearish stance, indicating that market momentum and price action have weakened. This technical perspective aligns with the recent downward movement in the stock price, which has declined by 0.63% on the day of the latest data and by 2.16% over the past month. Such technical signals often reflect investor sentiment and can influence short-term trading behaviour. The bearish technical grade, combined with the valuation concerns and mixed financial trends, has contributed to the overall revision in the company’s evaluation metrics. Investors and market watchers will likely continue to monitor SRF Ltd.’s financial trends and valuation metrics closely. The company’s ability to translate profit growth into sustained share price appreciation, while managing valuation expectations, will be critical in shaping future assessments. Additionally, sector dynamics within specialty chemicals and broader economic conditions will play a role in influencing the stock’s trajectory. The recent evaluation revision serves as a reminder of the multifaceted nature of stock assessment, where quality, valuation, financial trends, and technical factors must all be weighed carefully.

THREETREND RESEARCH

10 Aug • 10:08 PM · SEBI-Registered Analyst

Chemical Stocks

Top 5 chemical stocks to track in India are Pidilite Industries, Solar Industries India, SRF, PI Industries and Navin Fluorine International. These companies have strong positions across specialty chemicals, industrial products, agrochemicals and high-value fluorochemicals, and are among the chemical names highlighted by recent market screens and sector analyses. Investment in securities market is subject to market risks. This post is for educational purposes only and should not be considered investment advice or a recommendation to buy or sell any security.

SRF

DEEPAK PAL

8 Aug • 10:14 PM · SEBI-Registered Analyst

BREAKING----> US Tariff Threat Is Back, US Senate Approves 100% Tariff Power on India Over Russian Oil

A fresh trade-war risk has emerged for India. The US Senate has passed the “Lindsey O. Graham Sanctioning Russia and Iran Act of 2026” by an 86–11 vote, giving the US President the authority to impose tariffs of up to 100% on imports from countries that continue to buy significant amounts of Russian oil and gas, including India. But there is an important distinction: This is NOT a 100% tariff imposed on India yet. The bill still has to move through the US House of Representatives, and even if enacted, the tariff would be a presidential power rather than an automatic levy. ------->Which Indian Sectors Could Face Pressure? If such tariffs are eventually implemented, the impact would likely be highest on businesses with significant exposure to the US market. Textiles & Apparel •

GOKEX

• !Kitex Garments • !Pearl US demand is important for several Indian textile exporters, making tariff developments particularly relevant. Chemicals • !SRF • !PI Industries • !Navin Fluorine • !Aarti Industries Chemical exporters with meaningful US exposure could face pressure if additional tariffs are imposed. Pharma Indian pharmaceutical companies have substantial exposure to the US market. However, the exact impact would depend on which products are covered and whether exemptions are provided. Stocks to monitor: • !Sun Pharma • !Dr. Reddy's Laboratories • !Lupin • !Zydus Lifesciences @@But There Is Still a Long Way to Go The Senate vote is significant, but investors should not treat it as an immediate 100% tariff. The bill now faces the US House, where there are already concerns about giving the President such broad tariff powers. Therefore, the next major triggers will be: US House approval → Presidential action → Final tariff scope → Exemptions/waivers → India-US negotiations -----> Bottom Line 100% Tariff Threat, Not 100% Tariff Yet. The US Senate's decision has raised a fresh risk for Indian exporters,

SRF Ltd. Share Price

Overview

Market Data

Open Price

Prev. Close

Day Low

Day High

52 Week Low

52 Week High

Fundamentals

Quick Bite

Price To Earnings Ratio

Sector PE

PB Ratio

Sector PB

EPS

Dividend Yield

Today's Volume

5 Day Avg. Volume

PEG Ratio

Market Cap.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Mutual Fund Ownership

About SRF Ltd. 👋

Expert Opinions

News & Events

Frequently Asked Questions

What is the share price of SRF Ltd.?

What is the market cap of SRF Ltd.?

Should I buy SRF Ltd. stock now?

What is the 52 week high and low of SRF Ltd.?

Is the SRF Ltd. stock good to buy?

Is SRF Ltd. a good buy for the long term?

Is SRF Ltd. overvalued or undervalued?

What is the PE and PB ratio of SRF Ltd.?